SCHEMBL28998317

SCHEMBL28998317

Cn1ncc2ccc(NC(=O)OC(C)(C)C)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACSS2 Q9NR19 1/20 0.49
MAPK14 Q16539 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
NOTUM Q6P988 1/20 0.46
GSK3B P49841 1/20 0.45
DYRK1A Q13627 1/20 0.45
CYP17A1 P05093 1/20 0.44
MAPKAPK2 P49137 2/20 0.44
MAOB P27338 2/20 0.44
ACHE P22303 2/20 0.44
MAOA P21397 1/20 0.44
QPCT Q16769 1/20 0.43
RORC P51449 2/20 0.43
PDE1C Q14123 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
NAMPT P43490 1/20 0.43
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16406932 0.90 NOTUM (0.54) ACSS2MAPK14TRPV1NOTUMGSK3B
SCHEMBL28087693 0.85 EGFR (0.46) ACSS2MAPK14NOTUMGSK3BDYRK1A
SCHEMBL29522898 0.83 ALDH1A1 (0.50) MAPK14TRPV1NOTUMQPCTPDE1C
SCHEMBL28490404 0.83 ALDH1A1 (0.50) MAPK14TRPV1NOTUMQPCTPDE1C
SCHEMBL18136169 0.82 ACSS2 (0.44) ACSS2MAPK14NOTUMGSK3BDYRK1A
SCHEMBL29910097 0.81 CA12 (0.48) ACSS2MAPK14NOTUMGSK3BDYRK1A
SCHEMBL22920024 0.81 CA12 (0.48) ACSS2MAPK14NOTUMGSK3BDYRK1A
SCHEMBL31510405 0.81 HPGD (0.50) TRPV1NOTUMMAOBACHEMAOA
SCHEMBL4898390 0.80 TRPV1 (0.52) TRPV1NOTUMMAOBACHEMAOA
SCHEMBL30006626 0.80 MAPT (0.53) TRPV1NOTUMMAOBACHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311813-B Palladium-catalyzed meta-C-H functionalized universal ligands 斯克利普斯研究院 2023-02-28 CN disclosed